Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bloomapi
AddedFeb 16, 2024
UpdatedJun 18, 2026
Bloomapi

Bloomapi

Seed

BloomAPI streamlines medical record sharing for healthcare providers and patients.

HQ
Seattle, WA, US
Founded
2015
Accelerator
Y Combinator logoY CombinatorW17
Overview
Compare
Fundraising
Employees
Website

BloomAPI streamlines medical record sharing for healthcare providers and patients. The company offers secure, HIPAA-compliant texting services that allow doctors to share clinical data efficiently. Their platform supports secure communication with patients, clients, and family members, document scanning and file sharing, care coordination with staff, and broadcast SMS messaging. BloomAPI aims to replace outdated methods like fax and couriers, ensuring that medical records are available when needed for patient care.

BloomAPI has made significant strides in the healthcare industry by providing a user-friendly and secure solution for medical record sharing. Trusted by leading healthcare professionals, the platform enhances the efficiency of medical data transfer, benefiting patients, doctors, and insurance companies alike. The company's impact is evident in its ability to facilitate timely access to medical records, ultimately improving patient care and operational workflows within healthcare organizations.

Bloomapi - Similar Companies

Lexigram logo

Lexigram

lexigram.io

Metriport logo

Metriport

metriport.com

PatientBank logo

PatientBank

Eligible logo

Eligible

eligible.com

Codes Health logo

Codes Health

codeshealth.com

Bot MD logo

Bot MD

botmd.io

Medumo logo

Medumo

Morf Health logo

Morf Health

morf.health

Gradia Health logo

Gradia Health

gradia.com

Text2MD logo

Text2MD

text2md.com

ChartSynergy logo

ChartSynergy

CareMessage logo

CareMessage

caremessage.org

Medigram logo

Medigram

medigram.com

Sync logo

Sync

syncmd.com

Orchid logo

Orchid

orchid.health

Bloomapi - Quick Facts

Who are Bloomapi's competitors?

Companies similar to Bloomapi include Lexigram, Metriport, PatientBank and Eligible.

When was Bloomapi founded?

Bloomapi was founded in 2015.

Where is Bloomapi's headquarters located?

Bloomapi's headquarters is located in Seattle, WA, US.

When was Bloomapi's last funding round?

Bloomapi's most recent funding round was for $2.4M (USD) in July 2017.

How much has Bloomapi raised to-date?

As of Jul 13, 2017, Bloomapi has raised a total of $2.4M (USD).

How many employees does Bloomapi have?

Bloomapi has 7 employees as of Aug 23, 2023.

Bloomapi - Classification

Ownership
  • Private
Technology
  • API
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Records
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified